|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of deferred financing costs | |||||
| Credit loss expense (reversal), net | |||||
| Write-downs, including goodwill and asset impairments | |||||
| Deferred income tax expense (benefit) | |||||
| Share-based and other non-cash compensation | |||||
| Unrealized foreign currency exchange gain | |||||
| Realized and unrealized investment loss (gain) | |||||
| Induced conversion expense on settlement of convertible notes | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Film assets | |||||
| Deferred revenue | |||||
| Changes in other operating assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Purchase of property, plant and equipment | |||||
| Investment in equipment for joint revenue sharing arrangements | |||||
| Interest in film classified as a financial instrument | |||||
| Acquisition of other intangible assets | |||||
| Proceeds from sale of equity securities | |||||
| Acquisition of SSIMWAVE, net of cash and cash equivalents acquired | |||||
| Net cash used in investing activities | |||||
| Financing Activities | |||||
| Proceeds from issuance of convertible notes, net | |||||
| Redemption of capped calls related to convertible notes | |||||
| Debt issuance costs related to convertible notes | |||||
| Cash paid related to repurchase of convertible notes | |||||
| Purchase of capped calls related to convertible notes | |||||
| Proceeds from revolving credit facility borrowings | |||||
| Repayments of revolving credit facility borrowings | |||||
| Proceeds from other borrowings | |||||
| Repayment of other borrowings | |||||
| Credit facility amendment fees paid | |||||
| Repurchase of common shares | |||||
| IMAX Corporation | |||||
| IMAX China | |||||
| Taxes withheld and paid on employee stock awards vested | |||||
| Common shares issued - stock options exercised | |||||
| Principal payment under finance lease obligations | |||||
| Dividends paid to non-controlling interests | |||||
| Net cash used in financing activities | |||||
| Effects of exchange rate changes on cash | |||||
| Increase (decrease) in cash and cash equivalents during year | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
Loading...